what is microdosing with glp 1 Why GLP-1 Microdosing? A Closer Look at Reported Benefits GLP‑1 Microdosing Houston | Low‑Dose
Description
Response heterogeneity suggests underlying genetic influences
First-time prescribing First-time prescribing of AOM medications show similar trends to overall use
Adems, necesitan seguimiento clnico para ajustar dosis, monitorizar efectos secundarios y evaluar la respuesta individual
2024;12:e003218
doi: 10.1007/s12349-010-0043-6
Membrane depolarization by GLP-1 was mimicked by the PKC activator phorbol myristate acetate (PMA) and was not affected by treatment with either the PKA inhibitor myr-PKI, the K ATP channel blocker tolbutamide, or the L-type Ca 2+ channel inhibitor isradipine [514]
